Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and agree on...
Soona Amhaz, Bags $50 Million for New Crypto Fund
“I think it’s a phenomenal time to be investing,” Amhaz said. “This is the exact right time to be doubling down.”
Despite a nightmarish month...
Internet Stock Review Relaunches After 23 Years.
Our First Broad Based Recommended Watch List in Over Two Decades!
First name to our list of 20, is Snap Inc (SNAP) $13.00
What can we...
Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.
We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added to Watch List....
Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?
Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...
Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...
- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days -
- Results to be presented at PSYCH Symposium taking...
Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.
Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday. We've worked...
Report: Kerrisdale Capital on Up Fintech Holding (TIGR).
The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00!
LIVE QUOTE
Older report (February 2021), but the basic...
New Report: Lion Group Holdings (LGHL) Initiating Coverage. $1.07
Massive Long-Term Potential from Singapore based Rising Fintech Star.
A Fintech that nearly 'has it all' reported impressive (up 164% to $27 million) record numbers...
Report on Citius Pharma (CTXR): North Shore Research Issues a $10 Price Target, a...
We're Up 181% on Citius Pharma (CTXR), Despite its Being Well Below it's Recent High of $4.30. We Now Have Two $10 Price Targets....